| 基于WHO 958号技术报告分析基本药物目录遴选关注重点 |
| |
| 引用本文： | 杨悦,李延敏,宁艳阳,王华,罗列.基于WHO 958号技术报告分析基本药物目录遴选关注重点[J].中国药房,2011(32):2981-2983. |
| |
| 作者姓名： | 杨悦 李延敏 宁艳阳 王华 罗列 |
| |
| 作者单位： | 沈阳药科大学工商管理学院; |
| |
| 摘 要： | 目的:为我国基本药物遴选提供建议。方法:通过对WHO958号技术报告进行介绍,分析WHO基本药物目录遴选的关注重点。结果与结论:我国可通过提高认识、注重合作、完善目录格式、预审厂家资格、关注相关风险等措施来改进基本药物遴选方式。
|
| 关 键 词： | 世界卫生组织 基本药物 基本药物目录 遴选 |
Focus of the Selection of the Essential Drug List from WHO Technical Report Series 958 |
| |
| YANG Yue,LI Yan-min,NING Yan-yang,WANG Hua,LUO Lie.Focus of the Selection of the Essential Drug List from WHO Technical Report Series 958[J].China Pharmacy,2011(32):2981-2983. |
| |
| Authors: | YANG Yue LI Yan-min NING Yan-yang WANG Hua LUO Lie |
| |
| Institution: | YANG Yue,LI Yan-min,NING Yan-yang,WANG Hua,LUO Lie(School of Business Administration,Shenyang Pharmaceutical University,Shenyang 110016,China) |
| |
| Abstract: | OBJECTIVE:To give suggestions for the selection of the essential drugs in China. METHODS: The focus of the selection of the essential drug list was analyzed from introducing WHO technical report series 958. RESULTS & CONCLUSIONS: Our country can improve the essential drugs selecting mode by raising awareness, focusing on cooperation, and improving the format of the essential drug list, pre-qualifying manufacturers, concerning about the associated risks. |
| |
| Keywords: | WHO Essential drugs Essential drug list Selection |
| 本文献已被 CNKI 维普 等数据库收录！ |
|
